My WebLink
|
Help
|
About
|
Sign Out
Home
Browse
Search
2018-015A1
CBCC
>
Official Documents
>
2010's
>
2018
>
2018-015A1
Metadata
Thumbnails
Annotations
Entry Properties
Last modified
12/21/2020 11:37:35 AM
Creation date
5/9/2018 1:10:52 PM
Metadata
Fields
Template:
Official Documents
Official Document Type
Agreement
Approved Date
01/23/2018
Control Number
2018-015A1
Agenda Item Number
12.D.1.
Entity Name
RxBenefits
Subject
Administrative Services Agreement for Prescription Benefits
Alternate Name
Health Insurance Drug Benefits
There are no annotations on this page.
Document management portal powered by Laserfiche WebLink 9 © 1998-2015
Laserfiche.
All rights reserved.
/
38
PDF
Print
Pages to print
Enter page numbers and/or page ranges separated by commas. For example, 1,3,5-12.
After downloading, print the document using a PDF reader (e.g. Adobe Reader).
View images
View plain text
Multi -Source Generics <br />Generics in their FDC -granted exclusivity period <br />Patent litigated claims <br />Generics with limited supply <br />Generic medications prescribed and/or dispensed in conjunction with a specialty medication <br />5. All Claims filled in Most Favored Nation states are INCLUDED in discount guarantees. <br />6. All Claims filled in rural pharmacies are INCLUDED in discount guarantees. <br />7. Ingredient Cost (including Member share) is defined as the lesser of the following: <br />AWP -Discount %; <br />MAC Price; or <br />Usual & Customary Price. <br />8. Discount will always be calculated using this formula (all Claims, including ZBDs): <br />(1- [Ingredient Cost] / [AWP Price]) x 100. <br />9. "Gross Cost" is defined as: [Ingredient Cost] + [Dispensing Fee] + [Sales Tax]. <br />10. ESI agrees to apply Client -specific guarantees to all pricing components: <br />Discounts <br />Rebates <br />Admin Fees <br />Dispensing Fees <br />11. During the Term, contract guarantees will not change unless one of the following items occurs which could <br />change the economics of the pricing arrangement and would need to be evaluated: (i) a change in assumption <br />or plan design; (ii) change in law; and/or (iii) change in pricing benchmarks. <br />12. There will be NO dispensing fee applied to Reversed/Rejected Claims. <br />CLAIMS ADJUDICATION <br />13. There will be no price floors for amount paid on any Prescription Drug Claims. <br />REBATES <br />14. Rebate revenue will not have any impact on discount guarantee reporting and/or true up. <br />15. Rebates will be paid for brand Prescription Drug Claims and at a flat minimum dollar -for -dollar guarantee <br />basis <br />16. Contract rebate guarantees are not subject to change as a result of known brand patent expirations. <br />17. The rebate guarantees are not subject to formulary percentage criteria. <br />DATA <br />18. Audit files will be supplied to Client and Client's consultant directly from the source system and should include <br />all Prescription Drug Claims processed including, but not limited to, paid, reversed and denied Prescription <br />Drug Claims. <br />19. ESI will provide the above mentioned extract at no charge to Client. <br />NOT FOR DISTRIBUTION. THE INFORMATION CONTAINED HEREIN IS CONFIDENTIAL, PROPRIETARY <br />AND CONSTITUTES TRADE SECRETS OF ESI AND RXBENEFITS <br />30 <br />
The URL can be used to link to this page
Your browser does not support the video tag.